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Abstract 
 
Ameloblastoma is a locally aggressive tumor derived from odontogenic epithelium. Although 
benign, its clinical behavior may often times exhibit malignant characteristics. It is marked by 
slow and persistent growth with infiltration of adjacent tissues. Almost 70% occur in the 
mandible in patients over 30 years of age. Recurrence of ameloblastoma due to inadequate 
treatment is frequent. Due to its slow growth, recurrences may present decades after primary 
surgery. A primary ameloblastoma in an area outside of the mandible, maxilla and 
infratemporal fossa regions has not been described in detail to date, with only one possible 
case mentioned in literature. The authors present a case of primary temporal bone 
ameloblastoma in a 17-year-old male patient. The tumor originated in the left mastoid, 
infiltrating the lateral semicircular canal, facial nerve and cochlea, adhering to the sigmoid 
sinus and posterior cranial fossa dura. Although invasion of multiple structures in the 
infratemporal fossa and the temporal bone leads to variable disease presentation, this case is 
unique when considering that the first symptom of disease was unilateral recurring 
sensorineural sudden hearing loss. Surgery required transection of the facial nerve. 
Histopathology confirmed primary temporal bone ameloblastoma. The difficulties in 
achieving wide surgical margins, diagnostics and further management are also addressed. 
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Introduction 
 
Ameloblastoma is a locally aggressive tumor derived from odontogenic epithelium. [1] 
Almost 70% occur in the mandible in patients over 30 years of age. Although it is labeled as 
benign, its clinical behavior may often times exhibit malignant characteristics. It is marked by 
slow and persistent growth with infiltration of adjacent tissues. Recurrence of ameloblastoma 
due to inadequate treatment is frequent. [2] Due to its slow growth, recurrences may present 
decades after primary surgery. A primary ameloblastoma in an area outside of the mandible, 
maxilla and infratemporal fossa regions has not been described to date, with only one possible 
case mentioned in literature.
 
[3] 
 
Case report 
 
This case report describes a case of primary temporal bone ameloblastoma in a previously 
healthy 17-year-old male patient that presented with sudden sensorineural hearing loss on the 
left side. He had no previous history of dentition disorders or episodes of otitis and 
otoendoscopy was unremarkable. Following intravenous and oral corticosteroid therapy 
hearing was restored, but sudden hearing loss recurred a month later on the same side. 
Computed tomography imaging with contrast enhanced angiography was performed and a 
multicystic tumor was observed originating in the mastoid portion of the left temporal bone 
with infiltration of the lateral semicircular canal, cochlea, vestibular aqueduct as well as 
possible tympanic portion of facial nerve involvement. The sigmoid sinus and posterior 
cranial fossa dura showed tumor adherence and occipital condyle erosion. No significant 
contrast imbibition was observed, or posterior cranial dura imbibition, excluding possible 
paraganglioma or intraosseal meningeoma diagnoses. (Figures 1 and 2) A multidisciplinary 
tumor board was consulted and surgery was recommended. The mass was reduced through a 
left-sided mastoidectomy with multiple frozen histopathological section biopsies unable to 
confirm that the tumor was malignant. Likely facial nerve infiltration was noted and further 
surgery was prolonged until definitive histopathological diagnosis was available. Definitive 
histopathology confirmed primary temporal bone ameloblastoma and a second stage surgery 
in a joint oto-neurosurgical team effort was performed a month after the first stage. (Figure 3) 
A partial temporal bone resection including an extended mastoidectomy and a canal-wall-up 
tympanomastoidectomy revealed that the horizontal segment of the facial nerve was 
infiltrated and was resected until clear frozen histopathological section margins were 
obtained. The mastoid portion of the tumor was resected with noted adherence to posterior 
cranial fossa dura and jugular venous bulb and posterior cochlear and lateral semicircular 
canal bony erosion which was drilled out. Facial nerve decompression, transection and 
reanastomosis through neurorrhaphy was performed. Six months after surgery, the function of 
the facial nerve had a IV/VI House-Brackmann left-sided facial paresis score. The patient’s 
postoperative hearing threshold on the left side was normal up to 2 kHz, with deafness above 
3 kHz. The immediate postoperative course was uneventful and magnetic resonance imaging 
after 2 months of follow-up showed residual tumor tissue immediately laterally to the left 
occipital condyle and posteriorly to the jugular venous bulb, measuring 10x20x15 milimeters. 
The patient’s family was apprehensive of repeated surgery and the neurosurgical team advised 
an expectative approach, with magnetic resonance imaging after 1 month of follow-up and 7 
months of follow-up showing the tumor tissue being stationary in size and position. (Figures 4 
and 5)  
 
 
Discussion 
 
Although ameloblastoma represents 1% of all jaw tumors, found exclusively in the 
maxillofacial region, with only a single previous reports of a primary temporal bone 
ameloblastoma published and no information available on the tumors characteristics or patient 
outcome. [3] Both multicystic and unicystic ameloblastomas exhibit a propensity toward local 
infiltration and when located in the infratemporal fossa, may spread to the pterygopalatine 
fossa, parapharyngealspace, orbit, or intracranial space. Multicystic lesions behave more like 
solid tumors and have a higher recurrence rate than unicystic ameloblastomas. Up to 4.5% of 
ameloblastomas metastasize, and sometimes present metachronously in the mandible and the 
maxilla, but there have been no reports of temporal bone metastasis without clear primary 
tumor localization. There have been speculations on possible implantation of tumor cells in 
the temporal region during previous surgery in the mandible or infratemporal fossa, but our 
patient had no previous surgery and the lesion seemed to originate in the mastoid. [2]
 
The 
possible mechanism of spread in previously surgically treated patients may be incomplete 
enucleation of the cystic lining in the coronoid process, where unresected fibers of the 
temporal muscle attachment to the coronoid process act as a bridge for tumor cell 
implantation in the temporal bone. [4] The invasive borders of the tumor are diffuse, requiring 
adequate preoperative CT evaluation and resection planning. Margins of 3 centimeters and 
aggressive resection of solid and multicystic ameloblastomas correlates with a recurrence rate 
close to zero, due to reduction of residual tumor spread to locally fragmented bone through 
drilling close to the tumor.
 
[5]
 
It is often difficult to differentiate multicystic from unicystic 
ameloblastomas, possibly leading to an increased recurrence rate due to insufficient resection 
margins.
 
[5] Although invasion of multiple structures in the infratemporal fossa and the 
temporal bone leads to variable disease presentation, this case is unique when considering that 
the first symptom of disease was unilateral recurring sensorineural sudden hearing loss. 
Treatment of ameloblastoma is usually dependent on its varied biologic behavior, clinical 
manifestations and radiologic features.
 
[6] In this unique case the proximity and adherence of 
tumor tissue to vital surrounding structures make achieving these recommendations highly 
unlikely and optimal future treatment is currently uncertain.  
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Figure legends 
 
Figure 1. Preoperative computed tomographic scan showing an infiltrative multicystic 
ameloblastoma of the left temporal bone (arrow marking tumor position). 
 
 Figure 2. Preoperative computed tomographic scan showing an infiltrative multicystic 
ameloblastoma of the left temporal bone (arrow marking tumor position). 
 
 
 
 Figure 3. Histopathology showed a follicular growth pattern with tumor islands indicating 
peripheral and central cystic degeneration (hematoxylin-eosin stain, 200x). 
 
 
 
 Figure 4. Postoperative T1 FLAIR magnetic resonance image showing residual tumor tissue, 
surgery-related inflammation and liquid laterally to the left occipital condyle and posteriorly 
to the jugular venous bulb 1 month after surgery (arrow marking tumor position). 
 
 Figure 5. Postoperative T1 FLAIR magnetic resonance image showing residual tumor tissue 
laterally to the left occipital condyle and posteriorly to the jugular venous bulb 7 months after 
surgery (arrow marking tumor position). 
 
